LBA11 Neoadjuvant toripalimab plus lenvatinib and GEMOX in resectable, high-risk intrahepatic cholangiocarcinoma: A randomized, multicenter, open-label phase II-III clinical trialGuobang Shi, Jian Zou, Jing Fan et al.|Annals of Oncology|2025Cited by 2
Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons.Hui‐Chuan Sun, Haiqing Wang, Lianxin Liu et al.|Journal of Clinical Oncology|2022Cited by 1